CHCCG & HUHFT Joint Formulary

Back

Malignant disease
Malignant disease / Antibody responsive malignancy
	amivantamab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA850
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Rybrevant (Janssen-Cilag Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	atezolizumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA823 NICE TA638 NICE TA639 NICE TA666
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Tecentriq (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	avelumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA517 NICE TA691 NICE TA645 NICE TA788
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Bavencio (Merck Serono Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	belantamab mafodotin [Specialist drug]
	Powder for solution for infusion
	Blenrep (GlaxoSmithKline UK Ltd)
	bevacizumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA946
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Alymsys (Zentiva Pharma UK Ltd)
	Avastin (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Aybintio (Organon Pharma (UK) Ltd)
	Oyavas (Thornton & Ross Ltd)
	Vegzelma (Celltrion Healthcare UK Ltd)
	Versavo (Dr Reddy's Laboratories (UK) Ltd)
	Zirabev (Pfizer Ltd)
	blinatumomab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA450 NICE TA589
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for solution for infusion
	Blincyto (Amgen Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	brentuximab vedotin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA478 NICE TA641 NICE TA524 NICE TA577
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for solution for infusion
	Adcetris (Takeda UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	cemiplimab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA802
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Libtayo (Regeneron UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	cetuximab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668
	NICE does not recommend this medicine for the following indication TA242 - Cetuximab monotherapy or combination chemotherapy is not recommended for the treatment of patients with metastatic colorectal cancer that has progressed after first-line chemotherapy.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Erbitux (Merck Serono Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	daratumumab	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA763 NICE TA783 NICE TA897 NICE TA917 NICE TA959
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for injection
	Darzalex (Janssen-Cilag Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Darzalex (Janssen-Cilag Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	dinutuximab beta [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA538
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Qarziba (EUSA Pharma (UK) Ltd)
	dostarlimab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA779 NICE TA963
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Jemperli (GlaxoSmithKline UK Ltd)
	durvalumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA798 NICE TA944
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Imfinzi (AstraZeneca UK Ltd)
	elotuzumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Empliciti (Bristol-Myers Squibb Pharmaceuticals Ltd)
	elranatamab [Specialist drug]
	Solution for injection
	Elrexfio (Pfizer Ltd)
	enfortumab vedotin [Specialist drug]
	Powder for solution for infusion
	Padcev (Astellas Pharma Ltd)
	epcoritamab [Specialist drug]		NICE TA954
	Solution for injection
	Tepkinly (AbbVie Ltd)
	gemtuzumab ozogamicin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA545
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Mylotarg (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	glofitamab [Specialist drug]		NICE TA927
	Solution for infusion
	Columvi (Roche Products Ltd)
	inotuzumab ozogamicin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA541
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Besponsa (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	ipilimumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA268 NICE TA319 NICE TA400 NICE TA716 NICE TA724 NICE TA780 NICE TA818
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Yervoy (Bristol-Myers Squibb Pharmaceuticals Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	isatuximab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA658
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Sarclisa (Sanofi)	Non-formulary at HHFT and not suitable for primary care prescribing
	loncastuximab tesirine [Specialist drug]		NICE TA947
	Powder for solution for infusion
	Zynlonta (Swedish Orphan Biovitrum Ltd)
	mogamulizumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA754 NICE TA754
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Poteligeo (Kyowa Kirin Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	mosunetuzumab [Specialist drug]		NICE TA892
	Solution for infusion
	Lunsumio (Roche Products Ltd)
	nivolumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA384 NICE TA400 NICE TA684 NICE TA417 NICE TA780 NICE TA964 NICE TA462 NICE TA655 NICE TA713 NICE TA724 NICE TA876 NICE TA530 NICE TA817 NICE TA707 NICE TA746 NICE TA857 NICE TA865 NICE TA716 NICE TA736 NICE TA818
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Opdivo (Bristol-Myers Squibb Pharmaceuticals Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	nivolumab with relatlimab [Specialist drug]		NICE TA950
	Solution for infusion
	Opdualag (Bristol-Myers Squibb Pharmaceuticals Ltd)
	obinutuzumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA343 NICE TA513 NICE TA629
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Gazyvaro (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	panitumumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA242 NICE TA439
	NICE does not recommend this medicine for the following indication TA242 - Panitinumab monotherapy is not recommended for the treatment of patients with metastatic colorectal cancer that has progressed after first-line chemotherapy.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Vectibix (Amgen Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	pembrolizumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA357 NICE TA366 NICE TA766 NICE TA837 NICE TA428 NICE TA531 NICE TA683 NICE TA770 NICE TA692 NICE TA772 NICE TA540 NICE TA967 NICE TA650 NICE TA830 NICE TA858 NICE TA661 NICE TA709 NICE TA914 NICE TA737 NICE TA983 NICE TA801 NICE TA851 NICE TA939 NICE TA904
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Keytruda (Merck Sharp & Dohme (UK) Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	pertuzumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA424 NICE TA509 NICE TA569
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Perjeta (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	pertuzumab with trastuzumab [Specialist drug]
	Solution for injection
	Phesgo (Roche Products Ltd)
	polatuzumab vedotin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA649 NICE TA874
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Polivy (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	ramucirumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA378 NICE TA403
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Cyramza (Eli Lilly and Company Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	rituximab	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561
	Rituximab for malignancy The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s).
	Solution for injection
	MabThera (Roche Products Ltd)
	Solution for infusion
	MabThera (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Rixathon (Sandoz Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Ruxience (Pfizer Ltd)
	Truxima (Celltrion Healthcare UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Biosimilar Truxima is the preferred biosimilar brand of rituximab for non-malignancy indications
	sacituzumab govitecan [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA819
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Trodelvy (Gilead Sciences Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	siltuximab	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Sylvant (EUSA Pharma (UK) Ltd)
	tafasitamab [Specialist drug]		NICE TA883
	Powder for solution for infusion
	Minjuvi (Incyte Biosciences UK Ltd)
	talquetamab [Specialist drug]
	Solution for injection
	Talvey (Janssen-Cilag Ltd)
	teclistamab [Specialist drug]
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for injection
	Tecvayli (Janssen-Cilag Ltd)
	trastuzumab [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA34 NICE TA257 NICE TA509 NICE TA208
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Herceptin (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Herceptin (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Herzuma (Celltrion Healthcare UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Kanjinti (Amgen Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Ontruzant (Organon Pharma (UK) Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Trazimera (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Zercepac (Accord-UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	trastuzumab deruxtecan [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA704 NICE TA862
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for solution for infusion
	Enhertu (Daiichi Sankyo UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	trastuzumab emtansine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA458 NICE TA632
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Kadcyla (Roche Products Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	tremelimumab [Specialist drug]
	Solution for infusion
	Imjudo (AstraZeneca UK Ltd)
Malignant disease / Carcinoid syndrome
	telotristat ethyl	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Xermelo (SERB)
Malignant disease / Immunotherapy responsive malignancy
	Bacillus Calmette-Guérin [Specialist drug]	Hospital only
	Powder for reconstitution for instillation
	OncoTICE (Merck Sharp & Dohme (UK) Ltd)	Hospital only
	aldesleukin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Proleukin (Clinigen Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	interferon gamma-1b	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Immukin (Clinigen Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	lenalidomide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA322 NICE TA171 NICE TA586 NICE TA587 NICE TA627 NICE TA680
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral capsule
	Lenalidomide (Non-proprietary)
	Revlimid (Bristol-Myers Squibb Pharmaceuticals Ltd)
	mifamurtide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA235
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for suspension for infusion
	Mepact (Takeda UK Ltd)
	pomalidomide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA427
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral capsule
	Imnovid (Bristol-Myers Squibb Pharmaceuticals Ltd)
	talimogene laherparepvec [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA410
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Imlygic (Amgen Ltd)
	thalidomide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA228
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Talidex (Special Order)
	Oral capsule
	Thalidomide (Non-proprietary)
Malignant disease / Targeted therapy responsive malignancy
	abemaciclib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA563 NICE TA725 NICE TA810
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Verzenios (Eli Lilly and Company Ltd)
	acalabrutinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA689 NICE TA689
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Calquence (AstraZeneca UK Ltd)
	afatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA310
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Giotrif (Boehringer Ingelheim Ltd)
	aflibercept [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA294 NICE TA305 NICE TA346 NICE TA409 NICE TA486 NICE TA307
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for injection
	Eylea (Bayer Plc)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Zaltrap (Sanofi)	Non-formulary at HHFT and not suitable for primary care prescribing
	alectinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA536
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Alecensa (Roche Products Ltd)
	alpelisib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA816
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Piqray (Novartis Pharmaceuticals UK Ltd)
	asciminib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA813
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Scemblix (Novartis Pharmaceuticals UK Ltd)
	avapritinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Ayvakyt (Blueprint Medicines (UK) Ltd)
	axitinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA333 NICE TA645 NICE TA650
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Inlyta (Pfizer Ltd)
	belzutifan [Specialist drug]
	Oral tablet
	Welireg (Merck Sharp & Dohme (UK) Ltd)
	binimetinib [Specialist drug]		NICE TA562
	Oral tablet
	Mektovi (Pierre Fabre Ltd)
	bortezomib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA370 NICE TA311 NICE TA228 NICE TA129
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Bortezomib (Non-proprietary)
	Powder for solution for injection
	Bortezomib (Non-proprietary)
	Velcade (Janssen-Cilag Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	bosutinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA401
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Bosulif (Pfizer Ltd)
	brigatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA571 NICE TA670
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Form unstated
	Alunbrig (Takeda UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Alunbrig (Takeda UK Ltd)
	cabozantinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA463 NICE TA542 NICE TA964 NICE TA516 NICE TA928 NICE TA849
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Form unstated
	Cometriq (Ipsen Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Cabometyx (Ipsen Ltd)
	Oral capsule
	Cometriq (Ipsen Ltd)
	carfilzomib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA657 NICE TA695
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for solution for infusion
	Kyprolis (Amgen Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	ceritinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA395 NICE TA500
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Zykadia (Novartis Pharmaceuticals UK Ltd)
	cobimetinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA414
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Cotellic (Roche Products Ltd)
	crizotinib [Specialist drug]	Hospital only	NICE TA406 NICE TA422 NICE TA529
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Oral capsule
	Xalkori (Pfizer Ltd)
	dabrafenib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA321 NICE TA396 NICE TA544 NICE TA898
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Tafinlar (Novartis Pharmaceuticals UK Ltd)
	dacomitinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA595
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Vizimpro (Pfizer Ltd)
	dasatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA426 NICE TA425
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral suspension
	Sprycel (Imported (Germany))
	Oral tablet
	Dasatinib (Non-proprietary)
	Sprycel (Bristol-Myers Squibb Pharmaceuticals Ltd)
	Uxil (Zentiva Pharma UK Ltd)
	encorafenib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA562 NICE TA668
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Braftovi (Pierre Fabre Ltd)
	entrectinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA643 NICE TA644
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Rozlytrek (Roche Products Ltd)
	erlotinib [Specialist drug]	Hospital only	NICE TA227 NICE TA258 NICE TA374 NICE TA374
	Erlotinib is not approved for use at HUHFT for indications not recommended by NICE TA227 and TA374 NICE does not recommend this medicine for the following indications TA227 - Erlotinib monotherapy is not recommended for maintenance treatment in patients with locally advanced or metastatic non-small-cell lung cancer who have stable disease after platinum-based first-line chemotherapy. TA374 - Erlotinib is not recommended for treating locally advanced or metastatic non‑small‑cell lung cancer that has progressed after non‑targeted chemotherapy in patients with tumours that are EGFR‑TK mutation‑negative.
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Oral tablet
	Erlotinib (Non-proprietary)
	Tarceva (Roche Products Ltd)
	everolimus	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA421 NICE TA432 NICE TA449
	Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481
	Dispersible tablet
	Votubia (Novartis Pharmaceuticals UK Ltd)
	Oral tablet
	Everolimus (Non-proprietary)
	Afinitor (Novartis Pharmaceuticals UK Ltd)
	Certican (Novartis Pharmaceuticals UK Ltd)
	Votubia (Novartis Pharmaceuticals UK Ltd)
	fedratinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA756
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Inrebic (Bristol-Myers Squibb Pharmaceuticals Ltd)
	gefitinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA192 NICE TA374
	NICE does not recommend this medicine for the following indication TA374 - Gefitinib is not recommended for treating locally advanced or metastatic non‑small‑cell lung cancer that has progressed after non‑targeted chemotherapy in patients with tumours that are EGFR‑TK mutation‑positive.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Gefitinib (Non-proprietary)
	Iressa (AstraZeneca UK Ltd)
	gilteritinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA642
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Xospata (Astellas Pharma Ltd)
	glasdegib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Daurismo (Pfizer Ltd)
	ibrutinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA429 NICE TA891 NICE TA502 NICE TA795
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Imbruvica (Janssen-Cilag Ltd)
	idelalisib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA359 NICE TA604
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Zydelig (Gilead Sciences Ltd)
	imatinib [Specialist drug]	Hospital only	NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Imatinib is not approved for use at HUHFT for the treatment of hypereosinophilic syndrome Imatinib is not approved for use at HUHFT for the treatment of hypereosinophilic syndrome.
	Imatinib 600mg daily and 800mg daily doses are not approved for used as per NICE TA209 and TA425 NICE does not recommend the use of imatinib at 600mg daily and 800mg daily doses for the following indications NICE TA209 - Imatinib 600 mg daily or 800 mg daily is not recommended for unresectable or metastatic, or both, gastro-intestinal stromal tumours whose disease has progressed after treatment with imatinib 400 mg daily. NICE TA425 - High-dose imatinib (600 mg in the chronic phase or 800 mg in the accelerated and blast-crisis phases) is not recommended for treating Philadelphia-chromosome-positive CML in adults whose disease is imatinib-resistant.
	Oral tablet
	Imatinib (Non-proprietary)
	Glivec (Novartis Pharmaceuticals UK Ltd)
	ivosidenib [Specialist drug]		NICE TA948 NICE TA979
	Oral tablet
	Tibsovo (Servier Laboratories Ltd)
	ixazomib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA870
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Ninlaro (Takeda UK Ltd)
	lapatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA257
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Tyverb (Novartis Pharmaceuticals UK Ltd)
	larotrectinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA630
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral solution
	Vitrakvi (Bayer Plc)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Vitrakvi (Bayer Plc)
	lenvatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA535 NICE TA551 NICE TA498 NICE TA858 NICE TA904
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Kisplyx (Eisai Ltd)
	Lenvima (Eisai Ltd)
	lorlatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA628 NICE TA909
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Lorviqua (Pfizer Ltd)
	midostaurin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA523 NICE TA728
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Rydapt (Novartis Pharmaceuticals UK Ltd)
	mobocertinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA855
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	momelotinib [Specialist drug]		NICE TA957
	Oral tablet
	Omjjara (GlaxoSmithKline UK Ltd)
	neratinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA612
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Nerlynx (Pierre Fabre Ltd)
	nilotinib [Specialist drug]	Hospital only	NICE TA426 NICE TA425
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Oral capsule
	Tasigna (Novartis Pharmaceuticals UK Ltd)
	nintedanib	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA347 NICE TA379 NICE TA864 NICE TA747
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Ofev (Boehringer Ingelheim Ltd)
	Vargatef (Boehringer Ingelheim Ltd)
	niraparib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA673 NICE TA784
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Zejula (GlaxoSmithKline UK Ltd)
	olaparib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA908 NICE TA946 NICE TA962 NICE TA886 NICE TA887 NICE TA951
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Lynparza (AstraZeneca UK Ltd)
	osimertinib [Specialist drug]	Hospital only	NICE TA653 NICE TA654 NICE TA761
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Oral tablet
	Tagrisso (AstraZeneca UK Ltd)
	palbociclib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA495 NICE TA836
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Ibrance (Pfizer Ltd)
	pazopanib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA215
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Votrient (Novartis Pharmaceuticals UK Ltd)
	pemigatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA722
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Pemazyre (Incyte Biosciences UK Ltd)
	ponatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA451
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Ponatinib (Non-proprietary)
	pralsetinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA812
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral capsule
	Gavreto (Roche Products Ltd)
	quizartinib [Specialist drug]
	Oral tablet
	Vanflyta (Daiichi Sankyo UK Ltd)
	regorafenib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA488 NICE TA555 NICE TA866
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Stivarga (Bayer Plc)
	ribociclib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA496 NICE TA687
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Kisqali (Novartis Pharmaceuticals UK Ltd)
	ripretinib [Specialist drug]		NICE TA881
	Oral tablet
	Qinlock (Deciphera Pharmaceuticals (Netherlands) B.V.)
	rucaparib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA611
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Rubraca (pharmaand GmbH)
	ruxolitinib [Specialist drug]	Hospital only	NICE TA386 NICE TA921
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Jakavi (Novartis Pharmaceuticals UK Ltd)
	selinexor [Specialist drug]		NICE TA970 NICE TA974
	Oral tablet
	Selinexor (Non-proprietary)
	Nexpovio (Menarini Stemline UK Ltd)
	selpercatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA742 NICE TA760 NICE TA911
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Retsevmo (Eli Lilly and Company Ltd)
	sorafenib [Specialist drug]	Hospital only	NICE TA178 NICE TA474 NICE TA535
	Sorafenib is approved for use at HUHFT only for the treatment of advanced hepatocellular carcinoma as per NICE TA474 NICE TA474 - Sorafenib is approved for use at HUHFT only for the treatment of advanced hepatocellular carcinoma. NICE TA535 - Sorafenib is not approved for use at HUHFT for the treatment of differentiated thyroid cancer after radioactive iodine as the trust does not provide this service.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Sorafenib (Non-proprietary)
	Nexavar (Bayer Plc)
	sotorasib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA781
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Lumykras (Amgen Ltd)
	sunitinib [Specialist drug]	Hospital only	NICE TA169 NICE TA179 NICE TA178 NICE TA449
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Sunitinib is approved for use at HUHFT only for the treatment of gastrointestinal stromal tumour (NICE TA179) NICE TA179 - Sunitinib is approved for use at HUHFT only for the treatment of gastrointestinal stromal tumour. NICE TA169, TA178 and TA479 - Sunitinib is not approved for use at HUHFT for the treatment of the following conditions as the trust does not offer these services. Advanced or metastatic renal cell carcinoma. Unresectable or metastatic neuroendocrine tumours in people with progessive disease.
	Oral capsule
	Sunitinib (Non-proprietary)
	Sutent (Pfizer Ltd)
	talazoparib [Specialist drug]		NICE TA952
	Oral capsule
	Talzenna (Pfizer Ltd)
	tebentafusp [Specialist drug]
	Solution for infusion
	Kimmtrak (Immunocore Ltd)
	temsirolimus [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA178
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Torisel (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	tepotinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA789
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Tepmetko (Merck Serono Ltd)
	tivozanib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA512
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Fotivda (EUSA Pharma (UK) Ltd)
	trametinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA396 NICE TA544
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Mekinist (Novartis Pharmaceuticals UK Ltd)
	tucatinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA786
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Tukysa (Pfizer Ltd)
	vandetanib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA550
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Caprelsa (Sanofi)
	vemurafenib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA269
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Zelboraf (Roche Products Ltd)
	venetoclax [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA561 NICE TA663 NICE TA796 NICE TA765 NICE TA787
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Venclyxto (AbbVie Ltd)
	vismodegib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA489
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral capsule
	Erivedge (Roche Products Ltd)
	zanubrutinib [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA833 NICE TA931
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Brukinsa (BeiGene UK Ltd)
Malignant disease / Cytotoxic responsive malignancy
	amsacrine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Amsidine (Eurocept International bv)	Non-formulary at HHFT and not suitable for primary care prescribing
	arsenic trioxide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA526
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Arsenic trioxide (Non-proprietary)
	Trisenox (Teva UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	asparaginase [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Spectrila (medac UK)
	azacitidine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA218 NICE TA399 NICE TA827
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for suspension for injection
	Azacitidine (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Vidaza (Bristol-Myers Squibb Pharmaceuticals Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Onureg (Bristol-Myers Squibb Pharmaceuticals Ltd)
	bendamustine hydrochloride [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA216 NICE TA472
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Bendamustine hydrochloride (Non-proprietary)
	bexarotene [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Bexarotene (Non-proprietary)
	Targretin (Eisai Ltd)
	bleomycin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for injection
	Bleomycin (Non-proprietary)
	busulfan [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Busulfan (Non-proprietary)
	Oral tablet
	Busulfan (Non-proprietary)
	cabazitaxel [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA391
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Cabazitaxel (Non-proprietary)
	capecitabine [Specialist drug]	Hospital only	NICE TA263 NICE TA212 NICE TA191 NICE TA61 NICE TA100
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Capecitabine (Non-proprietary)
	carboplatin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA284 NICE TA285
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Carboplatin (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	carmustine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA121
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Prolonged-release intralesional implant
	Gliadel (Clinigen Healthcare Ltd)
	chlorambucil [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA343 NICE TA344
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Chlorambucil (Non-proprietary)
	chlormethine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA720
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Cutaneous gel
	Ledaga (Recordati Rare Diseases UK Ltd)
	cisplatin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Cisplatin (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	cladribine	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA616
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Litak (Lipomed GmbH)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Leustat (Atnahs Pharma UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Mavenclad (Merck Serono Ltd)
	clofarabine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Clofarabine (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	crisantaspase [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Erwinase (Porton Biopharma Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	cyclophosphamide	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Cyclophosphamide (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Cyclophosphamide (Non-proprietary)
	Cytoxan (Imported (United States))
	cytarabine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Cytarabine (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	dacarbazine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Dacarbazine (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Dacarbazine (Non-proprietary)
	daunorubicin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Daunorubicin (Non-proprietary)
	daunorubicin with cytarabine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA552
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Vyxeos (Jazz Pharmaceuticals UK Ltd)
	decitabine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for solution for infusion
	Dacogen (Janssen-Cilag Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	decitabine with cedazuridine [Specialist drug]
	Oral tablet
	Inaqovi (Otsuka Pharmaceuticals (U.K.) Ltd)
	docetaxel [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA101 NICE TA509
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Docetaxel (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	doxorubicin hydrochloride [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA389 NICE TA465
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Doxorubicin hydrochloride (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Doxorubicin hydrochloride (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	epirubicin hydrochloride [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Epirubicin hydrochloride (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Pharmorubicin (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Epirubicin hydrochloride (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Pharmorubicin (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	eribulin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA423 NICE TA515
	NICE TA515 The JPG agreed not to approve this medicine for treating locally advanced or metastatic breast cancer in adults who have had only 1 chemotherapy regimen as currently NICE cannot recommend its use.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Halaven (Eisai Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	NICE TA515 The JPG agreed not to approve this medicine for treating locally advanced or metastatic breast cancer in adults who have had only 1 chemotherapy regimen as currently NICE cannot recommend its use.
	estramustine phosphate [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	etoposide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Etopophos (Neon Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Etoposide (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Etoposide (Non-proprietary)
	fludarabine phosphate [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA119 NICE TA29
	NICE does not recommend this medicine for the following indication TA29 - Fludarabine monotherapy is not recommended for the first-line treatment of chronic lymphocytic leukaemia.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for injection
	Fludarabine phosphate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Fludarabine phosphate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Fludara (Sanofi)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Fludara (Sanofi)
	fluorouracil	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Fluorouracil (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Fluorouracil (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Cutaneous cream
	Fluorouracil (Non-proprietary)
	Efudix (Viatris UK Healthcare Ltd)
	gemcitabine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA25 NICE TA116 NICE TA285 NICE TA389 NICE TA476
	NICE does not recommend this medicine for the following indications TA285 - Bevacizumab in combination with gemcitabine and carboplatin is not recommended within its marketing authorisation, that is, for the treatment of the first recurrence of platinum-sensitive advanced ovarian cancer (including fallopian tube and primary peritoneal cancer) that has not been previously treated with bevacizumab or other vascular endothelial growth factor (VEGF) inhibitors or VEGF receptor-targeted agents. TA389 - Gemcitabine, in combination with carboplatin, is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Gemcitabine (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Gemcitabine (Non-proprietary)
	hydroxycarbamide	Non-formulary at HHFT and not suitable for primary care prescribing
	A formal Shared Care Guideline (SCG) may be available Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. Shared Care Guidelines Inappropriate request communication form
	Oral solution
	Xromi (Nova Laboratories Ltd)
	Oral tablet
	Siklos (Masters Pharmaceuticals Ltd)
	Oral capsule
	Hydroxycarbamide (Non-proprietary)
	Droxia (Imported (United States))
	Hydrea (Neon Healthcare Ltd)
	idarubicin hydrochloride [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Zavedos (Pfizer Ltd)
	ifosfamide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Ifosfamide (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	irinotecan hydrochloride [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA440
	NICE does not recommend this medicine for the following indication TA440 - Pegylated liposomal irinotecan, in combination with fluorouracil and leucovorin, is not recommended for treating metastatic adenocarcinoma of the pancreas in adults whose disease has progressed after gemcitabine-based therapy.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Irinotecan hydrochloride (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Campto (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Dispersion for infusion
	Onivyde (Servier Laboratories Ltd)
	lomustine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Lomustine (Non-proprietary)
	melphalan [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder and solvent for solution for injection
	Melphalan (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Melphalan (Non-proprietary)
	mercaptopurine	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral suspension
	Xaluprine (Nova Laboratories Ltd)
	Oral tablet
	Mercaptopurine (Non-proprietary)
	Hanixol (Fontus Health Ltd)
	methotrexate	Non-formulary at HHFT and not suitable for primary care prescribing
	A formal Shared Care Guideline (SCG) may be available Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. Shared Care Guidelines Inappropriate request communication form
	Oral solution
	Methotrexate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Jylamvo (Esteve Pharmaceuticals Ltd)
	Solution for injection
	Methotrexate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Methofill (Accord-UK Ltd)
	Metoject PEN (medac UK)	Non-formulary at HHFT and not suitable for primary care prescribing
	Nordimet (Nordic Pharma Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Zlatal (Nordic Pharma Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Methotrexate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Methotrexate (Non-proprietary)
	Maxtrex (Pfizer Ltd)
	mitomycin [Specialist drug]	Hospital only
	Powder for solution for injection
	Mitomycin (Non-proprietary)	Hospital only
	Mitocin (Vygoris Ltd)
	Powder and solvent for intravesical solution
	Mitomycin (Non-proprietary)
	mitotane [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Lysodren (HRA Pharma UK & Ireland Ltd)
	mitoxantrone [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Onkotrone (Baxter Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	nelarabine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Atriance (Sandoz Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	oxaliplatin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA100 NICE TA93
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Oxaliplatin (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	paclitaxel [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA55 NICE TA284 NICE TA389 NICE TA476
	NICE does not recommend this medicine for the following indications TA108 - Paclitaxel, within its licensed indication, is not recommended for the adjuvant treatment of women with early node-positive breast cancer. TA284 - Bevacizumab in combination with paclitaxel and carboplatin is not recommended for the first-line treatment of advanced ovarian cancer (including fallopian tube and primary peritoneal cancer).
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Paclitaxel (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for suspension for infusion
	Abraxane (Bristol-Myers Squibb Pharmaceuticals Ltd)
	panobinostat [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA380
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Farydak (pharmaand GmbH)
	pegaspargase [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA408
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for injection
	Oncaspar (Servier Laboratories Ltd)
	pemetrexed [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA124 NICE TA181 NICE TA402 NICE TA190 NICE TA135
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for infusion
	Pemetrexed (Non-proprietary)
	Powder for solution for infusion
	Pemetrexed (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Alimta (Eli Lilly and Company Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	pentostatin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Nipent (Pfizer Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	pixantrone [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA306
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Pixuvri (Servier Laboratories Ltd)
	procarbazine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Procarbazine (Non-proprietary)
	raltitrexed [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Powder for solution for infusion
	Tomudex (Pfizer Ltd)
	ropeginterferon alfa-2b [Specialist drug]
	Solution for injection
	Besremi (AOP Orphan Ltd)
	streptozocin [Specialist drug]
	Powder for solution for infusion
	Zanosar (Esteve Pharmaceuticals Ltd)
	tegafur with gimeracil and oteracil [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	temozolomide [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA23 NICE TA121
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral capsule
	Temozolomide (Non-proprietary)
	Temodal (Merck Sharp & Dohme (UK) Ltd)
	thiotepa [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Thiotepa (Non-proprietary)
	Tepadina (Adienne Pharma & Biotech)
	tioguanine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Tioguanine (Non-proprietary)
	topotecan [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA183 NICE TA184 NICE TA389
	NICE does not recommend this medicine for the following indication TA389 - Topotecan is not recommended for treating first recurrence of platinum‑sensitive ovarian cancer, recurrent platinum‑resistant ovarian cancer, or platinum‑refractory ovarian cancer.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Solution for infusion
	Topotecan (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Hycamtin (Sandoz Ltd)
	trabectedin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA185 NICE TA389
	NICE does not recommend this medicine for the following indication TA389 - Trabectedin in combination with pegylated liposomal doxorubicin hydrochloride (PLDH) is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer.
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for infusion
	Trabectedin (Non-proprietary)
	Yondelis (Immedica Pharma AB)	Non-formulary at HHFT and not suitable for primary care prescribing
	treosulfan [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA640
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Powder for solution for injection
	Treosulfan (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Trecondi (medac UK)
	tretinoin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Tretinoin (Non-proprietary)
	trifluridine with tipiracil [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA405 NICE TA852
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Lonsurf (Servier Laboratories Ltd)
	vinblastine sulfate [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Vinblastine sulfate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	vincristine sulfate [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Vincristine sulfate (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	vindesine sulfate [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for injection
	Eldisine (Genus Pharmaceuticals Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	vinorelbine [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for infusion
	Vinorelbine (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Vinorelbine The JPG agreed not to approve this medicine for use at the Homerton University Hospital Foundation Trust as the trust does not provide this specialist service.
	Navelbine (Pierre Fabre Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral capsule
	Vinorelbine (Non-proprietary)
	Navelbine (Pierre Fabre Ltd)
Malignant disease / Cytotoxic drug-induced side effects
	dexrazoxane	Non-formulary at HHFT and not suitable for primary care prescribing
	Powder for solution for infusion
	Cardioxane (CNX Therapeutics Ltd)
	Powder and solvent for solution for infusion
	Savene (Clinigen Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	folinic acid	Hospital only	NICE TA212
	Solution for injection
	Folinic acid (Non-proprietary)	Hospital only
	Sodiofolin (medac UK)	Hospital only
	Oral tablet
	Folinic acid (Non-proprietary)
	Refolinon (Pfizer Ltd)
	glucarpidase
	Powder for solution for injection
	Voraxaze (Protherics Medicines Development Ltd)
	levofolinic acid	Not approved for prescribing
	Solution for injection
	Levofolinic acid (Non-proprietary)
	Isovorin (Pfizer Ltd)	Not approved for prescribing
	mesna	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Mesna (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Mesna (Non-proprietary)
Malignant disease / Hyperuricaemia associated with cytotoxic drugs
	allopurinol	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Allopurinol (Non-proprietary)
	Zyloric (Aspen Pharma Trading Ltd)
	febuxostat	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA164
	Oral tablet
	Febuxostat (Non-proprietary)
	Adenuric (A. Menarini Farmaceutica Internazionale SRL)
	Elstabya (Amarox Ltd)
	rasburicase	Hospital only
	Powder and solvent for solution for infusion
	Fasturtec (Sanofi)	Hospital only
Malignant disease / Hormone responsive malignancy
	abiraterone acetate	Hospital only	NICE TA259 NICE TA387 NICE TA721
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Oral tablet
	Abiraterone acetate (Non-proprietary)
	Zytiga (Janssen-Cilag Ltd)
	apalutamide	Hospital only	NICE TA740 NICE TA741
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Oral tablet
	Apalutamide (Non-proprietary)
	Erleada (Janssen-Cilag Ltd)
	bicalutamide	Specialist knowledge/initiation
	Oral tablet
	Bicalutamide (Non-proprietary)
	Casodex (AstraZeneca UK Ltd)
	buserelin	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Buserelin (Non-proprietary)
	Suprefact (Neon Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Spray
	Suprecur (Neon Healthcare Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	cyproterone acetate	Specialist knowledge/initiation
	Oral tablet
	Cyproterone acetate (Non-proprietary)
	Androcur (Bayer Plc)
	Cyprostat (Bayer Plc)
	darolutamide	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA660 NICE TA903
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Oral tablet
	Nubeqa (Bayer Plc)
	degarelix	Hospital only	NICE TA404
	Powder and solvent for solution for injection
	Firmagon (Ferring Pharmaceuticals Ltd)	Hospital only
	diethylstilbestrol	Specialist knowledge/initiation
	Oral tablet
	Diethylstilbestrol (Non-proprietary)
	enzalutamide	Hospital only	NICE TA316 NICE TA377 NICE TA580 NICE TA712
	Where positive NICE Technology Appraisal(s) apply to this medicine This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Oral tablet
	Xtandi (Astellas Pharma Ltd)
	ethinylestradiol	Not approved for prescribing
	flutamide	Specialist knowledge/initiation
	Oral tablet
	Flutamide (Non-proprietary)
	goserelin	Shared care guideline
	A formal Shared Care Guideline (SCG) may be available Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. Shared Care Guidelines Inappropriate request communication form
	Prolonged-release subcutaneous implant
	Zoladex (AstraZeneca UK Ltd)
	Zoladex LA (AstraZeneca UK Ltd)
	lanreotide	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Lanreotide (Non-proprietary)
	Somatuline Autogel (Ipsen Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	leuprorelin acetate	Shared care guideline
	A formal Shared Care Guideline (SCG) may be available Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. Shared Care Guidelines Inappropriate request communication form
	Powder and solvent for suspension for injection
	Prostap 3 DCS (Takeda UK Ltd)	Shared care guideline
	A formal Shared Care Guideline (SCG) may be available Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. Shared Care Guidelines Inappropriate request communication form
	Prostap SR DCS (Takeda UK Ltd)	Shared care guideline
	A formal Shared Care Guideline (SCG) may be available Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. Shared Care Guidelines Inappropriate request communication form
	Prolonged-release subcutaneous implant
	Staladex (Aspire Pharma Ltd)
	medroxyprogesterone acetate	Non-formulary at HHFT and not suitable for primary care prescribing
	Suspension for injection
	Depo-Provera (Pfizer Ltd)
	Sayana Press (Pfizer Ltd)
	Oral tablet
	Provera (Pfizer Ltd)
	megestrol acetate	Specialist knowledge/initiation
	Oral suspension
	Megestrol acetate (Non-proprietary)	Specialist knowledge/initiation
	Oral tablet
	Megestrol acetate (Non-proprietary)
	Megace (Bausch & Lomb UK Ltd)
	norethisterone	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Noristerat (Bayer Plc)
	Oral tablet
	Norethisterone (Non-proprietary)
	Noriday (Pfizer Ltd)
	Primolut N (Bayer Plc)
	Utovlan (Pfizer Ltd)
	octreotide	Hospital only
	Agreement between the GP and the hospital This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.
	Solution for injection
	Octreotide (Non-proprietary)	Hospital only
	Agreement between the GP and the hospital This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.
	Sandostatin (Novartis Pharmaceuticals UK Ltd)	Hospital only
	Agreement between the GP and the hospital This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.
	Powder and solvent for suspension for injection
	Olatuton (Teva UK Ltd)
	Sandostatin LAR (Novartis Pharmaceuticals UK Ltd)	Hospital only
	Agreement between the GP and the hospital This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing.
	pasireotide	Not approved for prescribing
	Solution for injection
	Signifor (Recordati Rare Diseases UK Ltd)	Not approved for prescribing
	Powder and solvent for suspension for injection
	Signifor (Recordati Rare Diseases UK Ltd)
	relugolix
	Oral tablet
	Orgovyx (Accord-UK Ltd)
	triptorelin	Shared care guideline
	Powder and solvent for suspension for injection
	Decapeptyl SR (Ipsen Ltd)	Shared care guideline
	Gonapeptyl Depot (Ferring Pharmaceuticals Ltd)	Shared care guideline
	Salvacyl (Ipsen Ltd)	Shared care guideline
Malignant disease / Hormone responsive breast cancer
	anastrozole	Specialist knowledge/initiation
	Oral tablet
	Anastrozole (Non-proprietary)
	Arimidex (AstraZeneca UK Ltd)
	exemestane	Specialist knowledge/initiation
	Oral tablet
	Exemestane (Non-proprietary)
	Aromasin (Pfizer Ltd)
	fulvestrant	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA503
	Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for injection
	Fulvestrant (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Faslodex (AstraZeneca UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	letrozole	Specialist knowledge/initiation
	Oral tablet
	Letrozole (Non-proprietary)
	Femara (Novartis Pharmaceuticals UK Ltd)
	tamoxifen	Specialist knowledge/initiation
	Oral solution
	Tamoxifen (Non-proprietary)	Specialist knowledge/initiation
	Oral tablet
	Tamoxifen (Non-proprietary)
	toremifene	Hospital only
	Oral tablet
	Fareston (Orion Pharma (UK) Ltd)
Malignant disease / Photodynamic therapy responsive malignancy
	porfimer sodium [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	temoporfin [Specialist drug]	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Foscan (Biolitec Pharma Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
Malignant disease / Secondary bone metastases and hypercalcaemia
	calcitonin (salmon)	Non-formulary at HHFT and not suitable for primary care prescribing
	Solution for injection
	Calcitonin (salmon) (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	denosumab	Hospital only	NICE TA204 NICE TA265
	Where negative or terminated NICE Technology Appraisal(s) apply to this medicine This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
	Solution for injection
	Denosumab (Non-proprietary)
	Prolia (Amgen Ltd)
	Xgeva (Amgen Ltd)	Hospital only
	ibandronic acid	Non-formulary at HHFT and not suitable for primary care prescribing	NICE TA464
	Mixed formulary statuses The JPG agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided that it is used specifically in accordance with NICE Technology Appraisal(s). Specialist knowledge/initiation - Ibandronic acid tablets 150mg for the treatment of osteoporosis in adults Hospital only - Ibandronic acid 3mg solution for injection for the treatment of osteoporosis in adults Non-formulary at HUHFT. Hospital only for providers that have this on their formulary - Ibandronic acid is not approved for secondary bone metastases and hypercalcaemia
	Solution for injection
	Ibandronic acid (Non-proprietary)
	Bonviva (Atnahs Pharma UK Ltd)
	Solution for infusion
	Ibandronic acid (Non-proprietary)	Non-formulary at HHFT and not suitable for primary care prescribing
	Bondronat (Atnahs Pharma UK Ltd)	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Ibandronic acid (Non-proprietary)
	Bondronat (Atnahs Pharma UK Ltd)
	Bonviva (Atnahs Pharma UK Ltd)
	Iasibon (Aspire Pharma Ltd)
	pamidronate disodium	Hospital only
	Solution for infusion
	Pamidronate disodium (Non-proprietary)	Hospital only
	sodium clodronate	Non-formulary at HHFT and not suitable for primary care prescribing
	Oral tablet
	Clasteon (Kent Pharma (UK) Ltd)
	Loron (Esteve Pharmaceuticals Ltd)
	Oral capsule
	Sodium clodronate (Non-proprietary)
	Clasteon (Kent Pharma (UK) Ltd)
	zoledronic acid	Hospital only	NICE TA464
	Infusion
	Zoledronic acid (Non-proprietary)
	Aclasta (Sandoz Ltd)
	Zometa (Phoenix Labs Ltd)	Hospital only
	Solution for infusion
	Zoledronic acid (Non-proprietary)	Hospital only
	Zometa (Phoenix Labs Ltd)	Hospital only